psoriasis

Cellceutix Anti-Psoriasis Drug Prurisol Meets Primary Endpoint of Clinical Trial
Yahoo
Thu, 08/7/14 - 09:30 am
Cellceutix
psoriasis
Prurisol
clinical trials
Humira Still Key to AbbVie
Motley Fool
Sat, 07/26/14 - 10:10 am
AbbVie
Humira
psoriasis
Chron's Disease
rheumatoid arthritis
Novartis' Phase III Results on Secukinumab Published
Yahoo/Zacks.com
Thu, 07/10/14 - 11:30 am
psoriasis
secukinumab
Novartis
Pfizer Announces Detailed Results of OPT Compare Phase 3 Study of Tofacitinib 5 mg and 10 mg Twice Daily Compared to High-Dose ENBREL® in Adults with Moderate-to-Severe Chronic Plaque Psoriasis
Yahoo/BusinessWire
Sun, 03/23/14 - 09:48 am
Pfizer
tofacitinib
psoriasis
Experimental J&J psoriasis drug shows promise in study
Yahoo/Reuters
Sat, 03/22/14 - 12:10 pm
JNJ
psoriasis
guselkumab
AbbVie's Humira Still a Growth Engine
Motley Fool
Sun, 03/9/14 - 01:35 pm
AbbVie
Humira
rheumatoid arthritis
psoriasis
Idera: A Compelling Biotech Pick For March
Seeking Alpha
Fri, 03/7/14 - 12:12 pm
Idera Pharmaceuticals
psoriasis
autoimmune disease
Psoriasis study does little to help Pfizer with Xeljanz
Fierce Pharma
Fri, 10/11/13 - 09:37 am
Pfizer
psoriasis
Xeljanz
New class of psoriasis drugs being developed
Bloomberg
Fri, 10/4/13 - 10:14 am
psoriasis
Novartis
AstraZeneca
Amgen
Eli Lilly
Enbrel
secukinumab
brodalumab
IL-17 blockers
XenoPort to continue development of XP23829 after Phase 1 results
Yahoo/Fly on the Wall
Mon, 09/9/13 - 05:18 pm
XenoPort
XP23829
psoriasis
multiple sclerosis
Novartis' psoriasis drug superior to Enbrel in study
Reuters
Mon, 07/8/13 - 10:39 am
Novartis
psoriasis
Enbrel
secukinumab
Psoriasis Med Similiar To Biogen MS Pill Is Linked To Brain Disease
Pharmalot
Thu, 04/25/13 - 10:56 am
multiple sclerosis
Biogen Idec
psoriasis
PML
Tecfidera
Fumaderm
Is Celgene's Apremilast A Potential Blockbuster Or Not?
Seeking Alpha
Fri, 04/12/13 - 09:48 am
Celgene
apremilast
AbbVie
Amgen
JNJ
Humira
Stelara
psoriasis
Enbrel
Can Merck Field a Psoriasis Blockbuster?
Motley Fool
Tue, 04/9/13 - 09:44 am
Merck
psoriasis
MK-3222
Can New Psoriasis Drugs Scratch Investors' Itch?
Investors.com
Thu, 04/4/13 - 01:52 pm
investors
psoriasis
Amgen
Eli Lilly
Pfizer
Novartis
Celgene
Humira
AbbVie
Stelara
Remicade
Enbrel
apremilast
brodalumab
Xeljanz
2 Sides of Celgene's Apremilast Results
Motley Fool
Tue, 03/5/13 - 10:35 am
Celgene
apremilast
psoriasis
Do These Pipeline Drugs Hold the Key to AbbVie's Future?
Motley Fool
Sun, 03/3/13 - 11:32 am
AbbVie
GLPG0634
BT-061
rheumatoid arthritis
psoriasis
Celgene drug shown to be effective, safe in psoriasis trial
Reuters
Sun, 03/3/13 - 11:22 am
Cellgene
psoriasis
apremilast
Can Johnson & Johnson Cash In on Stelara?
Motley Fool
Sat, 02/9/13 - 12:06 pm
JNJ
Stelara
psoriasis
rheumatoid arthritis
Chron's Disease
Merck says psoriasis, HDL, Alzheimer's drug trials moving ahead
Reuters
Fri, 10/26/12 - 10:28 am
Merck
HDL cholesterol
psoriasis
Alzheimer's disease
Tredaptive
beta secretase inhibitor

Pages